FDA Inspection
Richard S. Finn, M.D.Richard S. Finn, M.D. – FDA Inspection, Nov 18, 2014
Record Details
This FDA Inspection record concerns Richard S. Finn, M.D., with an inspection on November 18, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Richard S. Finn, M.D.
- Inspection Date
- November 18, 2014
- Product Type
- Drugs
View Company Profile
ID · b2ce464e-6ace-4ae1-b657-7b03748ce3a8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 904127
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
5- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.53(c)(1)Investigator statement (FDA 1572)
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
- 21 CFR 50.20Consent not obtained, exceptions do not apply
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Richard S. Finn, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 27, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Richard S. Finn, M.D.
- FDA Inspection 981435 - 2016-07-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.